Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease

Dosluoglu, Hasan H.; Cherr, Gregory S.; Lall, Purandath; Harris, Linda M.; Dryjski, Maciej L.

doi:10.1016/j.jvs.2008.06.006

Cited by 62 publications

(47 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…22 Previous studies have compared bypass surgery with EVT, and Markose et al reported that bypass surgery with a vein graft resulted in a 2-year patency of 81%, compared with 67% for a PTFE graft and at best 67% for subintimal angioplasty. 23, 24 In Tables 1,2. group, it can be argued on the basis of this study that EVT should be the first-line treatment for patients with high operative risk. Careful patient selection is needed, however, because the primary patency rate of EVT was lower than that of bypass surgery.…”

Section: Outcome Of Evt Vs Bypassmentioning

confidence: 99%

Comparison of Long-Term Outcome After Endovascular Therapy Versus Bypass Surgery in Claudication Patients With Trans-Atlantic Inter-Society Consensus-II C and D Femoropopliteal Disease

Aihara

Soga

Mii

et al. 2014

Circ J

View full text Add to dashboard Cite

on behalf of the RECANALISE Registry Investigators Background: Although endovascular therapy (EVT) has advanced, few reports have compared EVT and bypass surgery in claudication patients with femoropopliteal disease. The present study used data from a multicenter registry in Japan to analyze outcomes of EVT and bypass surgery for claudication patients with Trans-Atlantic InterSociety Consensus (TASC)-II C and D femoropopliteal lesions. Methods and Results:Of 1,156 patients who underwent revascularization, 696 patients were treated for intermittent claudication. A total of 263 patients with femoropopliteal lesion were classified into TASC-II C and D. The primary and secondary patency rates of the EVT and bypass surgery groups were analyzed. The overall complication rate was 14.4% in the bypass surgery group and 3.5% in the EVT group (P<0.01). The 1-and 5-year primary patency rates were 82.1% and 69.4% in the bypass surgery group and 67.8% and 45.2% in the EVT group, respectively. Although the bypass surgery group had a higher primary patency rate than the EVT group (P<0.01, log-rank test), secondary patency rates did not differ significantly between the two groups. Conclusions:Although bypass surgery is clearly feasible for claudication patients with TASC-II C and D femoropopliteal disease, EVT is also a good option because of its lower complication rate and good secondary patency rate in patients in poor condition for bypass. (Circ J 2014; 78: 457 -464)

show abstract

Section: Outcome Of Evt Vs Bypassmentioning

confidence: 99%

Comparison of Long-Term Outcome After Endovascular Therapy Versus Bypass Surgery in Claudication Patients With Trans-Atlantic Inter-Society Consensus-II C and D Femoropopliteal Disease

Aihara

Soga

Mii

et al. 2014

Circ J

View full text Add to dashboard Cite

show abstract

“…Therefore, the procedure should be limited to cases in which the prospects for patency are satisfactory, especially when the competitive patency results in this sector are often reached with repeat endovascular procedures. The two-year percentages for secondary patency close to 70% are similar to those obtained with saphenous vein bypass (>70 after 2 years 3,9 ), and they surpass the patency of bypasses with prosthetic material (57% after 2 years and 37% after 5 years [10][11][12].…”

Section: Discussionmentioning

confidence: 59%

Predictors of Medium-term Patency in Percutaneous Endovascular Therapy of Femoro-popliteal Lesions

Velescu

Torres

Velasco

2015

Cirugía Española (English Edition)

View full text Add to dashboard Cite

“…There are not many publications comparing femoral artery stenting and bypass surgery, and the assessment of patency and the overall results of different treatment modalities is somewhat problematic, as study designs vary considerably. [16][17][18][19] In our series, 80% of TASC II A and B lesions received stents and 76% of TASC II C and D lesions received bypasses. These figures are in keeping with those reported in previous studies.…”

Section: Discussionmentioning

confidence: 59%

Comparison between superficial femoral artery stenting and bypass surgery in severe lower-limb ischaemia : a retrospective study : cardiovascular topic

Islam

Robbs

2015

CVJA

View full text Add to dashboard Cite

Background: Symptomatic femoro-popliteal disease is treated by bypass surgery or angioplasty with or without stenting. The aim of this study was to compare the results of stenting and bypass surgery with regard to limb salvage in patients with severe leg ischaemia. Methods: A total of 213 patients with femoro-popliteal disease presenting with severe claudication or critical limb ischaemia between January 2009 and December 2013 were evaluated; 118 patients (139 limbs) had stents placed and 95 patients (104 limbs) had bypass surgery. Most (60%) presented with critical limb ischaemia (rest pain 40%, tissue necrosis 20%), and the remainder with severe claudication. The treatment groups had matching risk factors. Results: The average age was 66 years and 73% were male. Tissue necrosis was found in 26% of the stent group and 12% of the bypass group (p = 0.009). In the stent group 26% had adjunctive procedures, compared to 16% in the bypass group (p = 0.138). During the one-year follow up, there were 30 stent occlusions (22%) and 18 graft occlusions (17%) (p = 0.42). There were 14 major amputations (10%) in the stent group, and 13 (13%) in the bypass group (p = 0.68). Limb salvage rate was 90% in the stent group, and 88% in the bypass group (p = 0.68). There were no peri-operative deaths in the stent group, but one in the bypass group (1%). One-year mortality rate was equal (8%) in both groups (p = 1.00). Conclusion: One-year outcome was comparable in both groups with regard to mortality, stent or graft patency and limb salvage rates.

show abstract

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease

Cited by 62 publications

References 39 publications

Comparison of Long-Term Outcome After Endovascular Therapy Versus Bypass Surgery in Claudication Patients With Trans-Atlantic Inter-Society Consensus-II C and D Femoropopliteal Disease

Comparison of Long-Term Outcome After Endovascular Therapy Versus Bypass Surgery in Claudication Patients With Trans-Atlantic Inter-Society Consensus-II C and D Femoropopliteal Disease

Predictors of Medium-term Patency in Percutaneous Endovascular Therapy of Femoro-popliteal Lesions

Comparison between superficial femoral artery stenting and bypass surgery in severe lower-limb ischaemia : a retrospective study : cardiovascular topic

Contact Info

Product

Resources

About